Determinants for the adoption of angiotensin II receptor blockers by general practitioners
- 1 December 2006
- journal article
- Published by Elsevier in Social Science & Medicine
- Vol. 63 (11) , 2890-2898
- https://doi.org/10.1016/j.socscimed.2006.07.019
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- International variation in prescribing antihypertensive drugs: Its extent and possible explanationsBMC Health Services Research, 2005
- Patient characteristics associated with prescribing of a newly introduced drug: the case of rofecoxibEuropean Journal of Clinical Pharmacology, 2005
- Does the early adopter of drugs exist? A population-based study of general practitioners? prescribing of new drugsEuropean Journal of Clinical Pharmacology, 2004
- Influence of commercial information on prescription quantity in primary careEuropean Journal of Public Health, 2002
- Scope and nature of prescribing decisions made by general practitionersQuality and Safety in Health Care, 2002
- Increasing response rates to postal questionnaires: systematic reviewBMJ, 2002
- Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololPublished by Elsevier ,2002
- Antihypertensive Drug Therapy in SaskatchewanArchives of internal medicine (1960), 2001
- How physicians choose drugsSocial Science & Medicine, 1988
- Scientific versus commercial sources of influence on the prescribing behavior of physiciansThe American Journal of Medicine, 1982